Validation of the chloramine-T induced oxidation of human serum albumin as a model for oxidative damage in vivo

The validity of using chloramine-T as a model compound for mimicing oxidative stress was examined using human serum albumin (HSA) as a model. Important sites of oxidation were studied by mild treatment with chloramine-T and by mutating 34Cys for a serine (C34S). High-performance liquid chromatograph...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmaceutical research 2003-04, Vol.20 (4), p.684-692
Hauptverfasser: ANRAKU, Makoto, KRAGH-HANSEN, Ulrich, KAWAI, Keiichi, MARUYAMA, Toru, YAMASAKI, Yasuomi, TAKAKURA, Yoshinobu, OTAGIRI, Masaki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 692
container_issue 4
container_start_page 684
container_title Pharmaceutical research
container_volume 20
creator ANRAKU, Makoto
KRAGH-HANSEN, Ulrich
KAWAI, Keiichi
MARUYAMA, Toru
YAMASAKI, Yasuomi
TAKAKURA, Yoshinobu
OTAGIRI, Masaki
description The validity of using chloramine-T as a model compound for mimicing oxidative stress was examined using human serum albumin (HSA) as a model. Important sites of oxidation were studied by mild treatment with chloramine-T and by mutating 34Cys for a serine (C34S). High-performance liquid chromatography (HPLC) combined with fluorescence detection to confirm the validity of chloramine-T as an oxidizing agent was used. Oxidized amino acid residues were detected by reaction with 5,5'-dithiobis(2-nitro benzoic acid), digestion with cyanogen bromide, followed by capillary electrophoresis. Protein conformation was examined by spectroscopic techniques. From the HPLC analysis of human serum, the validity of using chloramine-T as an oxidizing agent was confirmed. At low chloramine-T concentrations (CT0.1-HSA, CT1-HSA), 34Cys and Met residues were oxidized, at medium concentrations (CT10-HSA), the tryptophan residue also appeared to be oxidized, and at the highest concentration (CT50-HSA), the net charge of Site II of HSA was found to be more negative. The two highest levels of oxidation of HSA (CT10-HSA, CT50-HSA) resulted in conformational changes with an increased exposure of hydrophobic regions, decreased high-affinity bindings of warfarin and ketoprofen and a reduced esterase-like activity. The latter protein also has a shorter plasma half-life and an increased liver clearance. We succeeded in imitating oxidative damage to HSA using chloramine-T and the findings show that Site II is more affected than Site I and 34Cys, when HSA is exposed to oxidative stress.
doi_str_mv 10.1023/A:1023219420935
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_journals_222711985</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>404179501</sourcerecordid><originalsourceid>FETCH-LOGICAL-c312t-1ff8895be892b733dce249e1950323f9c84c47210d7a81744dfd44668ddaf19e3</originalsourceid><addsrcrecordid>eNpN0MtLw0AYBPBFFFurZ2-yCB6j-0p311spvqDgpYq38GUfNiXJ1t2k6H9vxBY9zeXHDAxC55RcU8L4zez2JxjVghHN8wM0prnkmSbi7RCNiWQiU1LQETpJaU0IUYM8RiPKJNdS6jEKr1BXFroqtDh43K0cNqs6RGiq1mVLXLW2N87i8PlPrfoGWpxc7BsMddkPFkPCgJtgXY19iHu_ddhCA-9uKMLbahtO0ZGHOrmzXU7Qy_3dcv6YLZ4fnuazRWY4ZV1GvVdK56VTmpWSc2scE9pRnRPOuNdGCSMko8RKUFQKYb0VYjpV1oKn2vEJuvzt3cTw0bvUFevQx3aYLBhjklKt8gFd7FBfNs4Wm1g1EL-K_T0DuNoBSAZqH6E1VfpzQvJc5Yx_A_Occ-c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>222711985</pqid></control><display><type>article</type><title>Validation of the chloramine-T induced oxidation of human serum albumin as a model for oxidative damage in vivo</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>ANRAKU, Makoto ; KRAGH-HANSEN, Ulrich ; KAWAI, Keiichi ; MARUYAMA, Toru ; YAMASAKI, Yasuomi ; TAKAKURA, Yoshinobu ; OTAGIRI, Masaki</creator><creatorcontrib>ANRAKU, Makoto ; KRAGH-HANSEN, Ulrich ; KAWAI, Keiichi ; MARUYAMA, Toru ; YAMASAKI, Yasuomi ; TAKAKURA, Yoshinobu ; OTAGIRI, Masaki</creatorcontrib><description>The validity of using chloramine-T as a model compound for mimicing oxidative stress was examined using human serum albumin (HSA) as a model. Important sites of oxidation were studied by mild treatment with chloramine-T and by mutating 34Cys for a serine (C34S). High-performance liquid chromatography (HPLC) combined with fluorescence detection to confirm the validity of chloramine-T as an oxidizing agent was used. Oxidized amino acid residues were detected by reaction with 5,5'-dithiobis(2-nitro benzoic acid), digestion with cyanogen bromide, followed by capillary electrophoresis. Protein conformation was examined by spectroscopic techniques. From the HPLC analysis of human serum, the validity of using chloramine-T as an oxidizing agent was confirmed. At low chloramine-T concentrations (CT0.1-HSA, CT1-HSA), 34Cys and Met residues were oxidized, at medium concentrations (CT10-HSA), the tryptophan residue also appeared to be oxidized, and at the highest concentration (CT50-HSA), the net charge of Site II of HSA was found to be more negative. The two highest levels of oxidation of HSA (CT10-HSA, CT50-HSA) resulted in conformational changes with an increased exposure of hydrophobic regions, decreased high-affinity bindings of warfarin and ketoprofen and a reduced esterase-like activity. The latter protein also has a shorter plasma half-life and an increased liver clearance. We succeeded in imitating oxidative damage to HSA using chloramine-T and the findings show that Site II is more affected than Site I and 34Cys, when HSA is exposed to oxidative stress.</description><identifier>ISSN: 0724-8741</identifier><identifier>EISSN: 1573-904X</identifier><identifier>DOI: 10.1023/A:1023219420935</identifier><identifier>PMID: 12739779</identifier><identifier>CODEN: PHREEB</identifier><language>eng</language><publisher>New York, NY: Springer</publisher><subject>Animals ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antioxidants ; Antiseptics ; Biological and medical sciences ; Chloramines - chemistry ; Chloramines - toxicity ; Disease Models, Animal ; Humans ; Medical sciences ; Mice ; Mutation ; Oxidation ; Oxidative stress ; Oxidative Stress - drug effects ; Oxidative Stress - genetics ; Pharmacology. Drug treatments ; Physiology ; Proteins ; Serum Albumin - chemistry ; Serum Albumin - drug effects ; Serum Albumin - genetics ; Tosyl Compounds - chemistry ; Tosyl Compounds - toxicity ; Validity</subject><ispartof>Pharmaceutical research, 2003-04, Vol.20 (4), p.684-692</ispartof><rights>2003 INIST-CNRS</rights><rights>Copyright Kluwer Academic Publishers Apr 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c312t-1ff8895be892b733dce249e1950323f9c84c47210d7a81744dfd44668ddaf19e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14735852$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12739779$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ANRAKU, Makoto</creatorcontrib><creatorcontrib>KRAGH-HANSEN, Ulrich</creatorcontrib><creatorcontrib>KAWAI, Keiichi</creatorcontrib><creatorcontrib>MARUYAMA, Toru</creatorcontrib><creatorcontrib>YAMASAKI, Yasuomi</creatorcontrib><creatorcontrib>TAKAKURA, Yoshinobu</creatorcontrib><creatorcontrib>OTAGIRI, Masaki</creatorcontrib><title>Validation of the chloramine-T induced oxidation of human serum albumin as a model for oxidative damage in vivo</title><title>Pharmaceutical research</title><addtitle>Pharm Res</addtitle><description>The validity of using chloramine-T as a model compound for mimicing oxidative stress was examined using human serum albumin (HSA) as a model. Important sites of oxidation were studied by mild treatment with chloramine-T and by mutating 34Cys for a serine (C34S). High-performance liquid chromatography (HPLC) combined with fluorescence detection to confirm the validity of chloramine-T as an oxidizing agent was used. Oxidized amino acid residues were detected by reaction with 5,5'-dithiobis(2-nitro benzoic acid), digestion with cyanogen bromide, followed by capillary electrophoresis. Protein conformation was examined by spectroscopic techniques. From the HPLC analysis of human serum, the validity of using chloramine-T as an oxidizing agent was confirmed. At low chloramine-T concentrations (CT0.1-HSA, CT1-HSA), 34Cys and Met residues were oxidized, at medium concentrations (CT10-HSA), the tryptophan residue also appeared to be oxidized, and at the highest concentration (CT50-HSA), the net charge of Site II of HSA was found to be more negative. The two highest levels of oxidation of HSA (CT10-HSA, CT50-HSA) resulted in conformational changes with an increased exposure of hydrophobic regions, decreased high-affinity bindings of warfarin and ketoprofen and a reduced esterase-like activity. The latter protein also has a shorter plasma half-life and an increased liver clearance. We succeeded in imitating oxidative damage to HSA using chloramine-T and the findings show that Site II is more affected than Site I and 34Cys, when HSA is exposed to oxidative stress.</description><subject>Animals</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antioxidants</subject><subject>Antiseptics</subject><subject>Biological and medical sciences</subject><subject>Chloramines - chemistry</subject><subject>Chloramines - toxicity</subject><subject>Disease Models, Animal</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mutation</subject><subject>Oxidation</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - drug effects</subject><subject>Oxidative Stress - genetics</subject><subject>Pharmacology. Drug treatments</subject><subject>Physiology</subject><subject>Proteins</subject><subject>Serum Albumin - chemistry</subject><subject>Serum Albumin - drug effects</subject><subject>Serum Albumin - genetics</subject><subject>Tosyl Compounds - chemistry</subject><subject>Tosyl Compounds - toxicity</subject><subject>Validity</subject><issn>0724-8741</issn><issn>1573-904X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpN0MtLw0AYBPBFFFurZ2-yCB6j-0p311spvqDgpYq38GUfNiXJ1t2k6H9vxBY9zeXHDAxC55RcU8L4zez2JxjVghHN8wM0prnkmSbi7RCNiWQiU1LQETpJaU0IUYM8RiPKJNdS6jEKr1BXFroqtDh43K0cNqs6RGiq1mVLXLW2N87i8PlPrfoGWpxc7BsMddkPFkPCgJtgXY19iHu_ddhCA-9uKMLbahtO0ZGHOrmzXU7Qy_3dcv6YLZ4fnuazRWY4ZV1GvVdK56VTmpWSc2scE9pRnRPOuNdGCSMko8RKUFQKYb0VYjpV1oKn2vEJuvzt3cTw0bvUFevQx3aYLBhjklKt8gFd7FBfNs4Wm1g1EL-K_T0DuNoBSAZqH6E1VfpzQvJc5Yx_A_Occ-c</recordid><startdate>20030401</startdate><enddate>20030401</enddate><creator>ANRAKU, Makoto</creator><creator>KRAGH-HANSEN, Ulrich</creator><creator>KAWAI, Keiichi</creator><creator>MARUYAMA, Toru</creator><creator>YAMASAKI, Yasuomi</creator><creator>TAKAKURA, Yoshinobu</creator><creator>OTAGIRI, Masaki</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20030401</creationdate><title>Validation of the chloramine-T induced oxidation of human serum albumin as a model for oxidative damage in vivo</title><author>ANRAKU, Makoto ; KRAGH-HANSEN, Ulrich ; KAWAI, Keiichi ; MARUYAMA, Toru ; YAMASAKI, Yasuomi ; TAKAKURA, Yoshinobu ; OTAGIRI, Masaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c312t-1ff8895be892b733dce249e1950323f9c84c47210d7a81744dfd44668ddaf19e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Animals</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antioxidants</topic><topic>Antiseptics</topic><topic>Biological and medical sciences</topic><topic>Chloramines - chemistry</topic><topic>Chloramines - toxicity</topic><topic>Disease Models, Animal</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mutation</topic><topic>Oxidation</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - drug effects</topic><topic>Oxidative Stress - genetics</topic><topic>Pharmacology. Drug treatments</topic><topic>Physiology</topic><topic>Proteins</topic><topic>Serum Albumin - chemistry</topic><topic>Serum Albumin - drug effects</topic><topic>Serum Albumin - genetics</topic><topic>Tosyl Compounds - chemistry</topic><topic>Tosyl Compounds - toxicity</topic><topic>Validity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ANRAKU, Makoto</creatorcontrib><creatorcontrib>KRAGH-HANSEN, Ulrich</creatorcontrib><creatorcontrib>KAWAI, Keiichi</creatorcontrib><creatorcontrib>MARUYAMA, Toru</creatorcontrib><creatorcontrib>YAMASAKI, Yasuomi</creatorcontrib><creatorcontrib>TAKAKURA, Yoshinobu</creatorcontrib><creatorcontrib>OTAGIRI, Masaki</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Pharmaceutical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ANRAKU, Makoto</au><au>KRAGH-HANSEN, Ulrich</au><au>KAWAI, Keiichi</au><au>MARUYAMA, Toru</au><au>YAMASAKI, Yasuomi</au><au>TAKAKURA, Yoshinobu</au><au>OTAGIRI, Masaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Validation of the chloramine-T induced oxidation of human serum albumin as a model for oxidative damage in vivo</atitle><jtitle>Pharmaceutical research</jtitle><addtitle>Pharm Res</addtitle><date>2003-04-01</date><risdate>2003</risdate><volume>20</volume><issue>4</issue><spage>684</spage><epage>692</epage><pages>684-692</pages><issn>0724-8741</issn><eissn>1573-904X</eissn><coden>PHREEB</coden><abstract>The validity of using chloramine-T as a model compound for mimicing oxidative stress was examined using human serum albumin (HSA) as a model. Important sites of oxidation were studied by mild treatment with chloramine-T and by mutating 34Cys for a serine (C34S). High-performance liquid chromatography (HPLC) combined with fluorescence detection to confirm the validity of chloramine-T as an oxidizing agent was used. Oxidized amino acid residues were detected by reaction with 5,5'-dithiobis(2-nitro benzoic acid), digestion with cyanogen bromide, followed by capillary electrophoresis. Protein conformation was examined by spectroscopic techniques. From the HPLC analysis of human serum, the validity of using chloramine-T as an oxidizing agent was confirmed. At low chloramine-T concentrations (CT0.1-HSA, CT1-HSA), 34Cys and Met residues were oxidized, at medium concentrations (CT10-HSA), the tryptophan residue also appeared to be oxidized, and at the highest concentration (CT50-HSA), the net charge of Site II of HSA was found to be more negative. The two highest levels of oxidation of HSA (CT10-HSA, CT50-HSA) resulted in conformational changes with an increased exposure of hydrophobic regions, decreased high-affinity bindings of warfarin and ketoprofen and a reduced esterase-like activity. The latter protein also has a shorter plasma half-life and an increased liver clearance. We succeeded in imitating oxidative damage to HSA using chloramine-T and the findings show that Site II is more affected than Site I and 34Cys, when HSA is exposed to oxidative stress.</abstract><cop>New York, NY</cop><pub>Springer</pub><pmid>12739779</pmid><doi>10.1023/A:1023219420935</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0724-8741
ispartof Pharmaceutical research, 2003-04, Vol.20 (4), p.684-692
issn 0724-8741
1573-904X
language eng
recordid cdi_proquest_journals_222711985
source MEDLINE; SpringerLink Journals
subjects Animals
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antioxidants
Antiseptics
Biological and medical sciences
Chloramines - chemistry
Chloramines - toxicity
Disease Models, Animal
Humans
Medical sciences
Mice
Mutation
Oxidation
Oxidative stress
Oxidative Stress - drug effects
Oxidative Stress - genetics
Pharmacology. Drug treatments
Physiology
Proteins
Serum Albumin - chemistry
Serum Albumin - drug effects
Serum Albumin - genetics
Tosyl Compounds - chemistry
Tosyl Compounds - toxicity
Validity
title Validation of the chloramine-T induced oxidation of human serum albumin as a model for oxidative damage in vivo
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T08%3A51%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Validation%20of%20the%20chloramine-T%20induced%20oxidation%20of%20human%20serum%20albumin%20as%20a%20model%20for%20oxidative%20damage%20in%20vivo&rft.jtitle=Pharmaceutical%20research&rft.au=ANRAKU,%20Makoto&rft.date=2003-04-01&rft.volume=20&rft.issue=4&rft.spage=684&rft.epage=692&rft.pages=684-692&rft.issn=0724-8741&rft.eissn=1573-904X&rft.coden=PHREEB&rft_id=info:doi/10.1023/A:1023219420935&rft_dat=%3Cproquest_pubme%3E404179501%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=222711985&rft_id=info:pmid/12739779&rfr_iscdi=true